![]() |
![]() |
|
|
Forward to a colleague |
||
Access Full Stories The first European approval application for a vaccine delivered via a new intradermal microinjection system developed by Becton Dickinson, has been filed by Sanofi-Pasteur... Read IMA positive about 2008 prospects despite slight 4th-qtr decline Fourth quarter operating profit at Italian packaging automation firm IMA SpA fell some 8.5 per cent to €27m, while its revenue for the period declined 4.2 per cent to €147m, although pharma sales, buoyed... Read FDA starts inspecting stalled Watson facility An end may be in sight to the long-running problems with the Florida manufacturing facility acquired by US brand and generic company Watson Pharmaceuticals with Andrx Corporation in November 2006... Read Novo Nordisk, Merck eyeing India Novo Nordisk and Merck & Co have both indicated they have their eye on expanding their drug discovery and manufacturing presence in India and forging new research partnerships among companies in the country. ... Read EU white paper urges competitive spirit in research The EMRC has called for increased funding within the European medical research community to maintain high standards and attract the brightest young researchers... Read |
||||||||||||||||||
All News Headlines for: February | January | December |
||||||||||||||||||
![]() Contract Biotechnology And Sterile Pharmaceutical Manufacturing Services Catalent Pharma Solutions offers a full range of manufacturing services from clinical through commercial-scale manufacturing and packaging. Multiple sites, capacity duplication and experience with almost every sterile dose form, make us the best choice for pharmaceutical... Click Here | ||||||||||||||||||
|
Related Industry News NIH-EPA toxicity agreement promises relief for lab animals A cross-agency agreement that should ease reliance on laboratory animals in testing for environmental toxins and generate data more relevant to humans has been signed by the National Institutes of Health (NIH)... Read Sigma-Aldrich smashes $2bn mark in 2007 sales Sigma-Aldrich has reported record annual revenues of $2.04bn in 2007, fuelled by strong growth in life science products and fine chemicals, favourable exchange rates and a $60m acquisition... Read SfN outlines strategies to counter animal extremists The threat of intimidation, harrassment and violence by animal extremist goups has prompted new recommendations detailing measures scientific institutions can take to protect laboratory researchers... Read EC 'unlikely to support ban on primate testing' The European Commission is unlikely to support an outright ban on the use of non-human primates in research, but has just published a new document which indicates that significant changes to current legislation... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||